Developing Salivary Components as Therapeutics for Oral Health (R21 Clinical Trial Not Allowed)

Funding Opportunity RFA-DE-24-005 from the NIH Guide for Grants and Contracts. This FOA will encourage interdisciplinary research that harnesses the functional components of saliva towards therapeutics. It is expected that outcomes will facilitate development of highly effective surrogate saliva for clinical applications.
Source: NIH Funding Opportunities (Notices, PA, RFA) - Category: Research Source Type: funding